Aquestive Therapeutics
AQST
AQST
52 hedge funds and large institutions have $62.9M invested in Aquestive Therapeutics in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.24% more ownership
Funds ownership: 38% → 40.24% (+2.2%)
2% less capital invested
Capital invested by funds: $64.4M → $62.9M (-$1.57M)
4% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $1.06M
Holders
52
Holding in Top 10
2
Calls
$1.02M
Puts
$1.06M
Top Buyers
| 1 | +$731K | |
| 2 | +$413K | |
| 3 | +$411K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$343K |
| 5 |
D.E. Shaw & Co
New York
|
+$341K |
Top Sellers
| 1 | -$775K | |
| 2 | -$697K | |
| 3 | -$646K | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$545K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$216K |